The Association of Indian Medical Device Industry (AiMed), wrote to the Union health minister Mansukh Mandaviya on Tuesday, urging to recall the draft bill. “After the initial invitation of comments we have not been invited for any discussions or the revised draft was not shared with us,” said Rajiv Nath, forum co-ordinator, AiMed.
A senior official from the FDA Maharashtra said there are continuous vigilance checks on online pharmacies considering they are not following the provisions of the Drugs and Cosmetics Act.
The Court said that the decision to manufacture something is taken by the entire board of directors of a company and hence, non-executive directors cannot escape liability.
The Indian Pharmacopoeia Commission has published the Indian Pharmacopoeia 2022 to supplement the current Indian Pharmacopoeia – the book of standards under the Drugs and Cosmetics Act,1940. IP 2022 is likely to be effective from December 1, 2022.